Genmab — Juli 2012
-
Alene en nicherotalty på 100 MDKK med 35% vækst er da over en milliard værd
-
så er der hele duobody teknologien
-
daratumumab
-
cash position
-
nej sukker, men mon ikke der bliver tricket noget ved blockbuster status
-
jeg har købt de frække.....
-
lidt dyrt. Sidst jeg købte kostede de 1,45 nu koster de 4,26
-
det ligner Rituaxian uptake på en PRIK!
-
-
jeg har købt nu solsen
-
faneme dejligt med de tal.
-
ja
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind